PSA PROFILES AFTER IODINE 125 PROSTATE BRACHYTHERAPY (BT)

被引：0
|
作者：
Crook, J. [1 ]
Gomez-Iturriga, A. [2 ]
Ma, C. [3 ]
Fung, S. [4 ]
机构：
[1] British Columbia Canc Agcy, Ctr Southern Interior, Dept Radiat Oncol, Kelowna, BC, Canada
[2] Univ Balboa, Dept Radiat Oncol, Balboa, Spain
[3] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON, Canada
[4] Princess Margaret Hosp, Biostat, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
309
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [21] Radiomic and dosiomic prediction of biochemical failure after Iodine-125 prostate brachytherapy
    Nakano, M.
    Ishiyama, H.
    Kawakami, S.
    Sekiguchi, A.
    Kainuma, T.
    Tsumura, H.
    Hashimoto, M.
    Hasegawa, T.
    Tanaka, Y.
    Katakura, T.
    Murakami, Y.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1595 - S1596
  • [22] A nalysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
    Du, E.
    Wang, Lin
    Li, Chang-ying
    Zhang, Chang-wen
    Qu, Yan-chun
    Liu, Ran-lu
    Xu, Yong
    Yang, Kuo
    Zhang, Zhi-hong
    ONCOTARGETS AND THERAPY, 2017, 10 : 2561 - 2567
  • [23] Five-year potency preservation after iodine-125 prostate brachytherapy
    Nishimura, Shuichi
    Yorozu, Atsunori
    Ohashi, Toshio
    Sakayori, Masanori
    Yagi, Yasuto
    Nishiyama, Toru
    Saito, Shiro
    Shiraishi, Yutaka
    Yoshida, Kayo
    Toya, Kazuhito
    Shigematsu, Naoyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (05) : 940 - 945
  • [24] Five-year potency preservation after iodine-125 prostate brachytherapy
    Shuichi Nishimura
    Atsunori Yorozu
    Toshio Ohashi
    Masanori Sakayori
    Yasuto Yagi
    Toru Nishiyama
    Shiro Saito
    Yutaka Shiraishi
    Kayo Yoshida
    Kazuhito Toya
    Naoyuki Shigematsu
    International Journal of Clinical Oncology, 2014, 19 : 940 - 945
  • [25] Prostatic length predicts functional outcomes after iodine-125 prostate brachytherapy
    Pal, Raj P.
    Bhatt, Jaimin R.
    Khan, Masood A.
    Duggleby, Stuart
    Camilleri, Philip
    Bell, C. Richard
    Elwell, Christine
    Kunkler, Roger B.
    BRACHYTHERAPY, 2011, 10 (02) : 107 - 116
  • [26] A prediction model for biochemical failure after salvage Iodine-125 prostate brachytherapy
    Peters, M.
    van Zyp, J. R. N. Van der Voort
    Moerland, M. A.
    Hoekstra, C. J.
    Van de Pol, S.
    Westendorp, H.
    Maenhout, M.
    Kattevilder, R.
    Verkooijen, H. M.
    Van Rossum, P. S. N.
    Ahmed, H. U.
    Shah, T.
    Emberton, M.
    Van Vulpen, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S28 - S29
  • [27] Salvage iodine-125 brachytherapy for local prostate cancer recurrence after radiotherapy
    Celada, F.
    Chicas, R.
    Soler, A.
    Roldan, S.
    Candela, C.
    Gimeno, J.
    Tormo, A.
    Perez-Calatayud, J.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S679 - S679
  • [28] PSA bounce after I-125 prostate brachytherapy correlates with better biochemical outcome
    Putora, P. M.
    Schwab, C.
    Engeler, D. S.
    Thoeni, A. F.
    Schiefer, J.
    Ackermann, D. K.
    Schmid, H. P.
    Plasswilm, L.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (12) : 1069 - 1069
  • [29] Calibration Seed Sampling for Iodine-125 Prostate Brachytherapy
    Crowe, Scott
    Kairn, Tanya
    WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING 2018, VOL 3, 2019, 68 (03): : 459 - 462
  • [30] The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapy
    Pina, Alfonso Gomez-Iturriaga
    Crook, Juanita Mary
    Kwan, Paul
    Borg, Jette
    Ma, Clement
    BRACHYTHERAPY, 2010, 9 (03) : 213 - 218
12345